Skip to main content
Reckitt Benckiser Group PLC logo

Reckitt Benckiser Group PLC — Investor Relations & Filings

Ticker · RKT ISIN · GB00B24CGK77 LEI · 5493003JFSMOJG48V108 IL Manufacturing
Open in API
Filings indexed 1,841 across all filing types
Latest filing 2020-03-09 Director's Dealing
Country GB United Kingdom
Listing IL RKT

About Reckitt Benckiser Group PLC

https://www.reckitt.com/

Reckitt Benckiser Group PLC is a global manufacturer of consumer products in the health, hygiene, and nutrition sectors. The company's mission is to protect, heal, and nurture in the pursuit of a cleaner, healthier world. It operates a portfolio of trusted brands, many of which hold market-leading positions in their categories. Key brands include Lysol, Dettol, Durex, Mucinex, Nurofen, Strepsils, Gaviscon, Finish, and Vanish. Leveraging scientific expertise and consumer insights, the company develops and distributes products designed to improve the daily lives of consumers worldwide, with over 30 million of its products sold daily.

Recent filings

Filing Released Lang Actions
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is explicitly labeled with an 'RNS Number' and contains the header 'NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM'. It details the purchase of shares by a Director/PDMR (Harold van den Broek) and his associated person. This type of insider transaction reporting is a specific regulatory disclosure. While it is a regulatory filing, the most specific category matching the content (Director's Dealing/Insider Trade) is 'DIRS'. The presence of the RNS header and the short nature of the filing (announcing a specific transaction) confirms it is a regulatory disclosure, but DIRS is more precise than RNS.
2020-03-09 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is titled 'RECKITT BENCKISER GROUP PLC - DIRECTOR/PDMR SHAREHOLDING' and details the purchase of shares by the Chief Executive Officer (Laxman Narasimhan) and an incoming CFO (Jeff Carr). This type of filing, reporting personal share transactions by company directors and executives, directly matches the definition for Director's Dealing. The presence of the RNS Number and the notification format confirms it is a regulatory disclosure, but the specific content points to DIRS over the general RNS category. The document length is short (3484 chars), but it is a specific disclosure, not an announcement *about* a report.
2020-03-03 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number' header and explicitly states it is provided by 'RNS, the news service of the London Stock Exchange'. The content details the total number of issued shares, treasury shares, and the resulting total voting rights as of a specific date (29 February 2020), referencing the Disclosure Guidance and Transparency Rules (DTR 5.6.1). This type of mandatory disclosure regarding capital structure and voting rights, disseminated via the RNS system, fits best under the general 'Regulatory Filings' category, as there is no specific code for 'Voting Rights Disclosure' that isn't tied to a general meeting result (DVA). Since it is a direct regulatory notification disseminated through the RNS system, RNS is the most appropriate classification.
2020-03-02 English
Full Year Results 2019
Earnings Release Classification · 98% confidence The document is titled '2019 RESULTS AND CONCLUSIONS OF STRATEGIC REVIEW' and contains detailed financial tables for Q4 and FY 2019, including Net Revenue, Operating Profit, and EPS figures. It also includes operational highlights, a CEO commentary on results and strategy, and a detailed section on the 'Conclusions from Strategic Review' outlining future plans and investment. This structure is characteristic of a comprehensive annual financial disclosure that summarizes performance and outlook, often released alongside or as part of the Annual Report process, but the content itself is a detailed summary of results and strategic direction, which aligns closely with the content typically found in an Earnings Release (ER) or a Management Discussion & Analysis (MDA) section of a larger report. Given the depth of financial data ('Results at a glance' table) and the extensive strategic commentary, it functions as both an initial results announcement and a management explanation. Since it provides the full set of key financial metrics (FY results) and a deep dive into performance drivers and outlook, it fits best as a Management Reports (MDA) or a very detailed Earnings Release (ER). However, the presence of the 'Strategic Review Conclusions' section, which explains performance issues and outlines a multi-year rejuvenation plan, strongly suggests this is the Management's detailed explanation of results and outlook, making MDA the most appropriate fit over a simple ER. The document is clearly not a short announcement (RPA) as it is very long (123k chars) and contains the full substance. FY 2019
2020-02-27 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is explicitly marked with an 'RNS Number' and contains information regarding the total issued ordinary shares, treasury shares, and total voting rights as of a specific date (31 January 2020), referencing the Disclosure Guidance and Transparency Rules (DTR 5.6.1). This type of notification, detailing capital structure changes relevant to voting rights, is a standard regulatory disclosure. While it relates to capital/voting rights, the format and source ('RNS Number', 'London Stock Exchange') strongly suggest it is a general regulatory announcement. Since there is no specific code for 'Voting Rights Notification' and it is a mandatory disclosure published via the RNS system, the most appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement that doesn't fit the more specific categories like DIV, SHA, or DVA (which is for *results* of votes, not the denominator for calculating votes). Given the document's brevity and nature as a formal notification distributed through the LSE's news service, RNS is the best fit.
2020-02-03 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is explicitly marked with an 'RNS Number' and contains information regarding the total number of issued shares, treasury shares, and the resulting total voting rights as of a specific date (31 December 2019). This type of mandatory disclosure, often related to capital structure or shareholder rights, is typically disseminated via regulatory news services. The content directly relates to 'Voting Rights and Capital' and is issued through RNS, which is the London Stock Exchange's news service. This fits best under the general 'Regulatory Filings' category (RNS) as it is a specific regulatory disclosure that doesn't map perfectly to the other specialized codes like DIV, SHA, or DVA (which is for voting *results*). Given the source (RNS Number) and the nature of the disclosure (voting rights denominator), RNS is the most appropriate classification.
2020-01-02 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.